BLR
BioLineRx
BLRX • NASDAQ
BioLineRx is a publicly traded company trading on NASDAQ, led by CEO Ella Sorani.
Employees79.0
CEOElla Sorani
CountryUnited States of America
Next EarningsMay 26, 2026 · in a monthQ1 2026
Financials
BLR
BioLineRx FAQ
Common questions about BioLineRx
BioLineRx is scheduled to report earnings for Q1 2026 on May 26, 2026. Analysts estimate revenue of $343.0K.
BioLineRx has approximately 79 employees.